Menopause and Hormones: Where Do We Stand? 

April 24, 2016
Connect with us

Menopause“Reluctance to treat menopausal symptoms has derailed and fragmented the clinical care of midlife women, creating a large and unnecessary burden of suffering” according to a March 3rd, 2016 editorial in the New England Journal of Medicine.

With the release of the Women’s Health Initiative study in 2002, many women and doctors alike became fearful of hormones to treat menopause. Little has changed since then in terms of the general perception. This fear has been fueled by the wildly overblow risk of breast cancer and the insinuation that hormones may cause heart problems.

Meanwhile, leading medical societies devoted to the care of postmenopausal women agree that hormone therapy is the most effective treatment for hot flashes, the prevention of osteoporosis, sexual dysfunction and more.

Multiple studies have shown that with the proper patient selection, and with the use of bio-identical hormones, there is actually an overall reduction in mortality, even a reduced risk of breast cancer and heart disease. See:

Postmenopausal Hormone Replacement Reduces Mortality Risk?

The mortality toll of estrogen avoidance

Where are we 10 years after the Women’s Health Initiative?

At Cenegenics, we understand hormones and the nuances of their use. As experts in hormone replacement therapy, we also believe that women don’t have to needlessly suffer from hot flashes, night sweats, poor sleep, depression, weight gain, osteoporosis and loss of libido.

With the proper treatment regimen, women can be safely and effectively treated not only for menopausal symptom control, but optimal health and disease prevention.

To learn about Cenegenics comprehensive programs contact me at 484.532.7003.


Connect with us
Posted in Blog, Medical News by admin